APOOL
gene geneOn this page
Also known as UNQ8193AAIR8193Mic27MICOS27
Summary
APOOL (apolipoprotein O like, HGNC:24009) is a protein-coding gene on chromosome Xq21.1, encoding MICOS complex subunit MIC27 (Q6UXV4). Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane.
This gene encodes a protein which contains an apolipoprotein O superfamily domain. This domain is found on proteins in circulating lipoprotein complexes.
Source: NCBI Gene 139322 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 117 total — 14 pathogenic, 1 likely-pathogenic
- GTEx eGene: eQTL in 28 tissues, sQTL in 5 (q < 0.05)
- MANE Select transcript:
NM_198450 - Notable: 117 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24009 |
| Approved symbol | APOOL |
| Name | apolipoprotein O like |
| Location | Xq21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | UNQ8193, AAIR8193, Mic27, MICOS27 |
| Ensembl gene | ENSG00000155008 |
| Ensembl biotype | protein_coding |
| OMIM | 300955 |
| Entrez | 139322 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay
MANE Select: ENST00000373173
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1
ENST00000373173, ENST00000895507, ENST00000895508, ENST00000990590, ENST00001089618, ENST00001098352, ENST00001134797
RefSeq mRNA: 1 — MANE Select: NM_198450
NM_198450
CCDS: CCDS48138
Canonical transcript exons
ENST00000373173 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001018759 | 85054344 | 85054398 |
| ENSE00001018761 | 85051389 | 85051508 |
| ENSE00001018762 | 85067127 | 85067218 |
| ENSE00001190497 | 85073998 | 85074111 |
| ENSE00001214782 | 85074274 | 85074391 |
| ENSE00001294157 | 85055827 | 85055925 |
| ENSE00001459714 | 85087590 | 85093315 |
| ENSE00001459717 | 85003877 | 85003927 |
| ENSE00001708477 | 85046446 | 85046550 |
Expression profiles
Bgee: expression breadth ubiquitous, 282 present calls, max score 95.20.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.0933 / max 107.3570, expressed in 1726 samples.
Highest expression (Bgee): skeletal muscle tissue of biceps brachii, biceps brachii, diaphragm, heart right ventricle, ventricle myocardium.
Genetic regulation across tissues (GTEx eQTL / sQTL)
APOOL is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 28 tissues and its splicing (sQTL) in 5 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 33 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Artery Tibial | eqtl | 3.4e-53 | +0.29 | X:85018942:GT:G |
| Artery Aorta | eqtl | 6.6e-31 | +0.29 | X:85081382:G:A |
| Pituitary | eqtl | 3.9e-30 | -0.42 | X:85043683:G:A |
| Muscle Skeletal | eqtl | 8.3e-29 | +0.17 | X:85088817:CAGTGAGCAAATTAGAAGAATAGGTTAGAAGAATAGGGTAGTAGATACTG:C |
| Thyroid | eqtl | 1.6e-22 | -0.22 | X:84959436:A:G |
| Cells Cultured fibroblasts | eqtl | 2.4e-21 | +0.28 | X:85088817:CAGTGAGCAAATTAGAAGAATAGGTTAGAAGAATAGGGTAGTAGATACTG:C |
| Adipose Subcutaneous | eqtl | 2.4e-12 | +0.17 | X:85125297:G:A |
| Nerve Tibial | eqtl | 4.6e-12 | +0.16 | X:85088817:CAGTGAGCAAATTAGAAGAATAGGTTAGAAGAATAGGGTAGTAGATACTG:C |
| Brain Substantia nigra | eqtl | 9.8e-11 | +0.28 | X:84983014:C:T |
| Cells EBV-transformed lymphocytes | eqtl | 3.0e-10 | +0.36 | X:85048896:C:G |
| Spleen | eqtl | 1.2e-08 | -0.24 | X:85094801:G:A |
| Liver | eqtl | 2.7e-08 | +0.22 | X:84929287:G:A |
| Artery Coronary | eqtl | 1.1e-06 | +0.19 | X:85061908:G:T |
| Testis | eqtl | 3.5e-06 | -0.09 | X:84959436:A:G |
| Colon Transverse | eqtl | 4.9e-06 | +0.14 | X:85073247:T:C |
| Breast Mammary Tissue | eqtl | 2.7e-05 | +0.13 | X:85125297:G:A |
| Skin Sun Exposed Lower leg | eqtl | 1.5e-04 | +0.40 | X:85032470:C:G |
| Adipose Visceral Omentum | eqtl | 1.7e-04 | +0.13 | X:85117441:G:T |
| Whole Blood | eqtl | 9.9e-04 | +0.10 | X:85125297:G:A |
| Kidney Cortex | eqtl | 1.6e-03 | +0.32 | X:84994784:C:T |
FANTOM5 promoters
1 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196838 | 10.0933 | 1726 |
Top tissues by expression
showing 100 of 294 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 95.20 | gold quality |
| biceps brachii | UBERON:0001507 | 94.52 | gold quality |
| diaphragm | UBERON:0001103 | 93.72 | gold quality |
| heart right ventricle | UBERON:0002080 | 93.13 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 92.68 | gold quality |
| blood vessel layer | UBERON:0004797 | 91.54 | gold quality |
| myocardium | UBERON:0002349 | 91.45 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 90.41 | gold quality |
| deltoid | UBERON:0001476 | 90.39 | gold quality |
| vastus lateralis | UBERON:0001379 | 90.33 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 90.30 | gold quality |
| quadriceps femoris | UBERON:0001377 | 90.00 | gold quality |
| parietal pleura | UBERON:0002400 | 89.97 | gold quality |
| hair follicle | UBERON:0002073 | 89.80 | silver quality |
| muscle tissue | UBERON:0002385 | 89.41 | gold quality |
| visceral pleura | UBERON:0002401 | 89.36 | gold quality |
| pleura | UBERON:0000977 | 89.18 | gold quality |
| endothelial cell | CL:0000115 | 88.91 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 88.68 | gold quality |
| tibialis anterior | UBERON:0001385 | 88.37 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 87.99 | gold quality |
| buccal mucosa cell | CL:0002336 | 87.92 | gold quality |
| tibia | UBERON:0000979 | 87.90 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 87.03 | gold quality |
| nephron tubule | UBERON:0001231 | 86.39 | gold quality |
| upper leg skin | UBERON:0004262 | 86.21 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 86.19 | gold quality |
| colonic mucosa | UBERON:0000317 | 86.09 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 86.07 | gold quality |
| cauda epididymis | UBERON:0004360 | 86.01 | gold quality |
| muscle organ | UBERON:0001630 | 86.00 | gold quality |
| corpus epididymis | UBERON:0004359 | 85.96 | gold quality |
| nipple | UBERON:0002030 | 85.91 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 85.89 | gold quality |
| kidney epithelium | UBERON:0004819 | 85.38 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 85.35 | gold quality |
| squamous epithelium | UBERON:0006914 | 85.31 | gold quality |
| jejunum | UBERON:0002115 | 85.24 | gold quality |
| caput epididymis | UBERON:0004358 | 85.13 | gold quality |
| jejunal mucosa | UBERON:0000399 | 84.98 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 84.81 | gold quality |
| oral cavity | UBERON:0000167 | 84.41 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 84.28 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 84.26 | gold quality |
| entorhinal cortex | UBERON:0002728 | 84.22 | gold quality |
| postcentral gyrus | UBERON:0002581 | 84.17 | gold quality |
| skin of hip | UBERON:0001554 | 84.13 | gold quality |
| muscle of leg | UBERON:0001383 | 84.04 | gold quality |
| seminal vesicle | UBERON:0000998 | 83.99 | gold quality |
| gastrocnemius | UBERON:0001388 | 83.80 | gold quality |
| adrenal tissue | UBERON:0018303 | 83.73 | gold quality |
| superficial temporal artery | UBERON:0001614 | 83.47 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.33 | gold quality |
| liver | UBERON:0002107 | 83.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 83.16 | gold quality |
| lower lobe of lung | UBERON:0008949 | 83.13 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 82.97 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 82.94 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 82.91 | gold quality |
| cardia of stomach | UBERON:0001162 | 82.72 | gold quality |
| cardiac ventricle | UBERON:0002082 | 82.72 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 82.68 | gold quality |
| islet of Langerhans | UBERON:0000006 | 82.52 | gold quality |
| heart left ventricle | UBERON:0002084 | 82.44 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 82.41 | gold quality |
| parietal lobe | UBERON:0001872 | 82.36 | gold quality |
| gingival epithelium | UBERON:0001949 | 82.34 | gold quality |
| oviduct epithelium | UBERON:0004804 | 82.27 | gold quality |
| renal glomerulus | UBERON:0000074 | 82.08 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 82.07 | gold quality |
| mammalian vulva | UBERON:0000997 | 81.86 | gold quality |
| metanephros | UBERON:0000081 | 81.84 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 81.83 | gold quality |
| mammary duct | UBERON:0001765 | 81.78 | gold quality |
| gingiva | UBERON:0001828 | 81.77 | gold quality |
| ileal mucosa | UBERON:0000331 | 81.71 | gold quality |
| kidney | UBERON:0002113 | 81.67 | gold quality |
| heart | UBERON:0000948 | 81.58 | gold quality |
| saphenous vein | UBERON:0007318 | 81.46 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 81.44 | gold quality |
| popliteal artery | UBERON:0002250 | 81.34 | gold quality |
| tibial artery | UBERON:0007610 | 81.32 | gold quality |
| mammary gland | UBERON:0001911 | 81.30 | gold quality |
| sperm | CL:0000019 | 81.01 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 80.94 | silver quality |
| pons | UBERON:0000988 | 80.89 | gold quality |
| decidua | UBERON:0002450 | 80.71 | silver quality |
| renal medulla | UBERON:0000362 | 80.55 | gold quality |
| cortex of kidney | UBERON:0001225 | 80.48 | gold quality |
| bronchial epithelial cell | CL:0002328 | 80.46 | gold quality |
| aorta | UBERON:0000947 | 80.46 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 80.46 | gold quality |
| duodenum | UBERON:0002114 | 80.45 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 80.42 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 80.31 | gold quality |
| medial globus pallidus | UBERON:0002477 | 80.16 | gold quality |
| male germ cell | CL:0000015 | 80.09 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.01 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 79.85 | silver quality |
| descending thoracic aorta | UBERON:0002345 | 79.85 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6678 | yes | 647.06 |
| E-ANND-3 | yes | 7.65 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Choroid plexus | tissue | 20.9 | |
| Postcentral gyrus | tissue | 19.8 | |
| Locus coeruleus | tissue | 19.4 | |
| Olfactory bulb | tissue | 17.8 | |
| Spinal cord | tissue | 17.0 | |
| Hippocampus | tissue | 17.0 | not detected |
| Skeletal muscle | tissue | 16.7 | not detected |
| Tongue | tissue | 16.7 | |
| Cerebellum | tissue | 15.7 | medium |
| Nucleus accumbens | tissue | 15.5 | |
| Corpus callosum | tissue | 15.3 | |
| Medulla oblongata | tissue | 14.5 | |
| Liver | tissue | 13.5 | medium |
| Substantia nigra | tissue | 13.4 | |
| Superior colliculi | tissue | 13.0 | |
| Cerebral cortex | tissue | 12.7 | medium |
| Insular cortex | tissue | 12.7 | |
| Hippocampal formation | tissue | 12.5 | |
| Periaqueductal gray | tissue | 12.5 | |
| Basal ganglia | tissue | 12.4 | low |
| Midbrain | tissue | 12.4 | |
| Pons | tissue | 12.3 | |
| Putamen | tissue | 12.3 | |
| Amygdala | tissue | 12.2 | |
| Retrosplenial cortex | tissue | 12.2 | |
| Retrosplenial and cingulate cortex | tissue | 12.1 | |
| Septum | tissue | 12.1 | |
| Thalamus | tissue | 12.0 | |
| Hypothalamus | tissue | 11.6 | |
| Entorhinal cortex | tissue | 11.6 | |
| Temporal cortex | tissue | 11.4 | |
| Prefrontal cortex | tissue | 11.2 | |
| Ventral forebrain | tissue | 11.2 | |
| Motor cortex | tissue | 11.1 | |
| Occipital cortex | tissue | 11.1 | |
| Parathyroid gland | tissue | 10.9 | medium |
| Heart muscle | tissue | 10.8 | high |
| Somatosensory cortex | tissue | 10.6 | |
| Kidney | tissue | 10.4 | medium |
| Caudate putamen | tissue | 7.9 | |
| Thyroid gland | tissue | 7.8 | low |
| Stomach 1 | tissue | 6.4 | medium |
| Skin 1 | tissue | 6.3 | medium |
| Breast | tissue | 6.2 | medium |
| Retina | tissue | 6.2 | |
| Adrenal gland | tissue | 6.2 | medium |
| Rectum | tissue | 6.1 | high |
| Frontal cortex | tissue | 6.0 | |
| Esophagus | tissue | 5.8 | low |
| Pancreas | tissue | 5.7 | high |
| Adipose tissue | tissue | 5.5 | not detected |
| Salivary gland | tissue | 5.5 | medium |
| Smooth muscle | tissue | 5.5 | medium |
| Colon | tissue | 5.5 | medium |
| Duodenum | tissue | 5.5 | medium |
| Prostate | tissue | 5.5 | medium |
| Fallopian tube | tissue | 4.8 | not detected |
| Epididymis | tissue | 4.5 | |
| Small intestine | tissue | 4.3 | medium |
| Seminal vesicle | tissue | 4.2 | medium |
Brain sub-regions (HPA Brain Atlas): detected in 190; highest nTPM — Lateral geniculate body (19.1), Spinal trigeminal nucleus, interpolar (19.0), Pulvinar (18.6), Median raphe nucleus (18.5), Medial vestibular nucleus (18.4).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting APOOL by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 249 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-3162-3P | 100.00 | 65.37 | 363 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
Functional genomics
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000373173 — one region, missense o/e 1.06.
Literature-anchored findings (GeneRIF, showing 2)
- APOOL is a cardiolipin-binding component of the Mitofilin/MINOS protein complex. (PMID:23704930)
- MIC26 and MIC27 cooperate to regulate cardiolipin levels and the landscape of OXPHOS complexes. (PMID:32788226)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | apool | ENSDARG00000039374 |
| mus_musculus | Apool | ENSMUSG00000025525 |
| rattus_norvegicus | Apool | ENSRNOG00000082020 |
| drosophila_melanogaster | Mic26-27 | FBGN0038400 |
| caenorhabditis_elegans | WBGENE00019333 |
Paralogs (1): APOO (ENSG00000184831)
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Pongo abelii | Q5NVS6 | 98.7% | Diamond |
| Bos taurus | Q148H0 | 86.9% | Diamond |
| Gallus gallus | Q5ZK55 | 68.1% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| HDX | protein-coding | 139324 |
| SATL1 | protein-coding | 340562 |
| MIR548I4 | ncRNA | 100302191 |
| ZNF711 | protein-coding | 7552 |
| POF1B | protein-coding | 79983 |
| MIR1321 | ncRNA | 100302171 |
Protein
Protein identifiers
MICOS complex subunit MIC27 — Q6UXV4 (reviewed: Q6UXV4)
Alternative names: Apolipoprotein O-like, Protein FAM121A
All UniProt accessions (1): Q6UXV4
UniProt curated annotations — full annotation on UniProt →
Function. Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane. Specifically binds to cardiolipin (in vitro) but not to the precursor lipid phosphatidylglycerol. Plays a crucial role in crista junction formation and mitochondrial function,.
Subunit / interactions. Component of the mitochondrial contact site and cristae organizing system (MICOS) complex, composed of at least MICOS10/MIC10, CHCHD3/MIC19, CHCHD6/MIC25, APOOL/MIC27, IMMT/MIC60, APOO/MIC23/MIC26 and MICOS13/MIC13. This complex was also known under the names MINOS or MitOS complex. The MICOS complex associates with mitochondrial outer membrane proteins SAMM50, MTX1 and MTX2 (together described as components of the mitochondrial outer membrane sorting assembly machinery (SAM) complex) and DNAJC11, mitochondrial inner membrane protein TMEM11 and with HSPA9. The MICOS and SAM complexes together with DNAJC11 are part of a large protein complex spanning both membranes termed the mitochondrial intermembrane space bridging (MIB) complex. Interacts with MICOS10/MIC10, IMMT/MIC60 and APOO/MIC23/MIC26.
Subcellular location. Mitochondrion inner membrane. Mitochondrion.
Similarity. Belongs to the apolipoprotein O/MICOS complex subunit Mic27 family.
RefSeq proteins (1): NP_940852* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019166 | MIC26/MIC27 | Family |
| IPR033182 | MIC26/MIC27_animal | Family |
Pfam: PF09769
UniProt features (11 total): topological domain 3, transmembrane region 2, compositionally biased region 2, transit peptide 1, chain 1, modified residue 1, region of interest 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UXV4-F1 | 70.83 | 0.30 |
Human Protein Atlas
Protein class: Predicted membrane proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): mitochondria
Antibody reliability (HPA): IH approved · IF enhanced
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1)
| Type | Positions |
|---|---|
| Phosphoserine | 204 |
Function
Pathways and Gene Ontology
Reactome pathways
1 curated (TAS) of 7; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
7 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-114608 | Platelet degranulation | curated |
| R-HSA-8949613 | Cristae formation | electronic |
| R-HSA-109582 | Hemostasis | — |
| R-HSA-1592230 | Mitochondrial biogenesis | — |
| R-HSA-1852241 | Organelle biogenesis and maintenance | — |
| R-HSA-76002 | Platelet activation, signaling and aggregation | — |
| R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | — |
MSigDB gene sets: 171 (showing top):
GOCC_SECRETORY_GRANULE, REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_CRISTAE_FORMATION, GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION, GOCC_MITOCHONDRIAL_ENVELOPE, BASAKI_YBX1_TARGETS_DN, GOBP_MEMBRANE_ORGANIZATION, GATA1_02, ISRE_01, GATA_Q6, EVI1_04, SENESE_HDAC3_TARGETS_DN, GOCC_PLATELET_ALPHA_GRANULE, GOCC_SECRETORY_VESICLE
GO Biological Process (2): inner mitochondrial membrane organization (GO:0007007), cristae formation (GO:0042407)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): SAM complex (GO:0001401), extracellular region (GO:0005576), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), platelet alpha granule lumen (GO:0031093), mitochondrial crista junction (GO:0044284), MICOS complex (GO:0061617), MIB complex (GO:0140275)
Reactome top-level categories
5 top-level categories:
| Category | Pathways |
|---|---|
| Response to elevated platelet cytosolic Ca2+ | 1 |
| Mitochondrial biogenesis | 1 |
| Organelle biogenesis and maintenance | 1 |
| Hemostasis | 1 |
| Platelet activation, signaling and aggregation | 1 |
GO top-level categories
14 GO namespaces:
| Category | Terms |
|---|---|
| inner mitochondrial membrane protein complex | 2 |
| mitochondrial membrane organization | 1 |
| inner mitochondrial membrane organization | 1 |
| binding | 1 |
| mitochondrial outer membrane translocase complex | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| platelet alpha granule | 1 |
| secretory granule lumen | 1 |
| mitochondrial inner membrane | 1 |
| organelle membrane contact site | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 4 of 11 annotations. The rest are phylogenetic / computational / electronic (IEA).
4 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| MIB complex | CC | high-throughput assay |
| MICOS complex | CC | direct assay |
| SAM complex | CC | high-throughput assay |
| mitochondrion | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 870 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| APOOL | CHCHD6 | Q9BRQ6 | 871 |
| APOOL | CHCHD3 | Q9NX63 | 833 |
| APOOL | MICOS13 | Q5XKP0 | 805 |
| APOOL | MICOS10 | Q5TGZ0 | 794 |
| APOOL | IMMT | Q16891 | 787 |
| APOOL | SAMM50 | Q9Y512 | 751 |
| APOOL | MTX2 | O75431 | 717 |
| APOOL | DNAJC11 | Q9NVH1 | 713 |
| APOOL | APOO | Q9BUR5 | 702 |
| APOOL | MTX1 | Q13505 | 580 |
| APOOL | ZNF711 | Q9Y462 | 572 |
| APOOL | SATL1 | Q86VE3 | 547 |
| APOOL | CHCHD5 | Q9BSY4 | 540 |
| APOOL | CYLC1 | P35663 | 527 |
| APOOL | CHCHD10 | Q8WYQ3 | 504 |
IntAct
Human interaction partners of APOOL in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
4 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| MTX2 | association | 0.530 | 3 |
| BNRF1 | physical association | 0.370 | 1 |
| ALDH1L1 | association | 0.350 | 1 |
| MGST3 | association | 0.350 | 1 |
BioGRID (115 interactions; top human partners by supporting records): AIFM1 (Affinity Capture-MS; 4 records), SFXN1 (Affinity Capture-MS; 3 records), APOO (Affinity Capture-MS; 2 records), C1orf85 (Affinity Capture-MS; 2 records), CHCHD3 (Affinity Capture-MS; 2 records), CHCHD6 (Affinity Capture-MS; 2 records), IMMT (Affinity Capture-MS; 2 records), MTX2 (Affinity Capture-MS; 2 records), SAMM50 (Affinity Capture-MS; 2 records), SLC15A1 (Affinity Capture-MS; 2 records), SLC1A1 (Affinity Capture-MS; 2 records), SLC25A46 (Affinity Capture-Western; 2 records), SLC39A12 (Affinity Capture-MS; 2 records), AFG3L2 (Affinity Capture-MS), AQP3 (Affinity Capture-MS)
Protein complexes (CORUM) (2)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
2 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| MIB complex, mitochondrial | 12 | MTX1, SAMM50, CHCHD3, DNAJC11, MICOS10, MTX2, MTX3, APOO, APOOL, CHCHD6, IMMT, MICOS13 |
| MICOS complex, mitochondrial | 7 | CHCHD6, IMMT, MICOS10, MICOS13, APOO, APOOL, CHCHD3 |
Disease & clinical
Genetic variants
Variant evidence for APOOL: 117 ClinVar records (15 pathogenic / likely pathogenic). Per-variant detail is on Sugi Variant.
ClinVar
117 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 14 |
| Likely pathogenic | 1 |
| Uncertain significance | 37 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (15)
Showing all 15 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 57134 | GRCh38/hg38 Xq21.1-21.31(chrX:79372269-91308122)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 57928 | GRCh38/hg38 Xq21.1-21.2(chrX:80329330-86150446)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 57931 | GRCh38/hg38 Xq21.1-21.2(chrX:81762601-86471468)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 57965 | GRCh38/hg38 Xq21.1-21.2(chrX:81762602-86457999)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 57967 | GRCh38/hg38 Xq21.1-21.2(chrX:81765008-86444979)x0 | Pathogenic | criteria provided, single submitter | 1 |
| 831865 | NC_000023.10:g.(?83126460)(86924394_?)del | Pathogenic | criteria provided, single submitter | 1 |
| 832734 | NC_000023.10:g.(?83576897)(86924394_?)del | Pathogenic | criteria provided, single submitter | 1 |
| 833457 | NC_000023.10:g.(?82763333)(86924394_?)del | Pathogenic | criteria provided, single submitter | 1 |
| 833482 | NC_000023.10:g.(?83372068)(86924394_?)del | Pathogenic | criteria provided, single submitter | 1 |
| 1526822 | GRCh37/hg19 Xq21.1-21.2(chrX:78104966-86189374)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 4683020 | GRCh37/hg19 Xq21.1-22.3(chrX:77574432-106660031)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 1807759 | GRCh37/hg19 Xq21.1-21.2(chrX:84343474-84990478)x0 | Likely pathogenic | criteria provided, single submitter | 1 |
| 146002 | GRCh38/hg38 Xq21.1-21.2(chrX:81930916-85965282)x1 | Pathogenic | no assertion criteria provided | 1 |
| 150837 | GRCh38/hg38 Xq21.1-21.31(chrX:80722314-92152619)x0 | Pathogenic | no assertion criteria provided | 1 |
| 686630 | GRCh37/hg19 Xq13.3-21.31(chrX:74667077-90312981)x1 | Pathogenic | no assertion criteria provided | 1 |
Per-variant reference — Sugi Variant
Explore APOOL’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 36 predictions of 908):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| X:85055815 | acceptor_gain | 1.0000 | |
| X:85046444–85046445 | acceptor_loss | 0.9900 | 5 |
| X:85051387–85051388 | acceptor_loss | 0.9900 | 6 |
| X:85051509–85051510 | donor_loss | 0.9900 | 5 |
| X:85055823 | acceptor_gain | 0.9900 | |
| X:85067125–85067126 | acceptor_loss | 0.9900 | 6 |
| X:85067219–85067220 | donor_loss | 0.9900 | 5 |
| X:85087717 | donor_gain | 0.9900 | |
| X:85003928–85003929 | donor_loss | 0.9800 | 5 |
| X:85046436 | acceptor_loss | 0.9800 |
AlphaMissense
227 missense substitutions predicted likely pathogenic (of 1,726 scored), across 87 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D260 | 8 | 0.790 | 0.908 |
| D252 | 8 | 0.784 | 0.884 |
| D262 | 7 | 0.721 | 0.774 |
| P154 | 6 | 0.770 | 0.864 |
| G254 | 6 | 0.767 | 0.828 |
| R267 | 5 | 0.849 | 0.914 |
| S265 | 5 | 0.844 | 0.933 |
| F111 | 5 | 0.833 | 0.889 |
| S268 | 5 | 0.821 | 0.919 |
| C152 | 5 | 0.780 | 0.931 |
| Y264 | 5 | 0.739 | 0.848 |
| G125 | 4 | 0.773 | 0.909 |
| F65 | 4 | 0.740 | 0.745 |
| Y44 | 4 | 0.662 | 0.733 |
| Y153 | 4 | 0.639 | 0.750 |
| G148 | 3 | 0.913 | 0.927 |
| G143 | 3 | 0.903 | 0.908 |
| I118 | 3 | 0.875 | 0.903 |
| G122 | 3 | 0.873 | 0.884 |
| G116 | 3 | 0.863 | 0.884 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
2 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 2.54e-09 |
| Breast Invasive Carcinoma (TCGA) | unfavorable | 6.52e-05 |
Disease associations
OMIM: gene MIM:300955 | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases methylation, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression, increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| glycidyl methacrylate | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Bortezomib | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Cisplatin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Rotenone | increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Isotretinoin | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SD01 | HAP1 APOOL (-) 1 | Cancer cell line | Male |
| CVCL_SD02 | HAP1 APOOL (-) 2 | Cancer cell line | Male |
| CVCL_SD03 | HAP1 APOOL (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.